Source: International Congress 2014 – Systemic biomarkers for airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. McCrae, Y. Zhou, J. Qian, J. Xia, C. Wang, M. van Geest, R. Tang, L. Zheng, C. Liu, A. Nilsson, M. Zhang, Z. Taib, J. Zheng, P. Bruijnzeel, Y. Gu, R. Chen, N. Zhong (Mölndal, Sweden; Guangzhou, Shanghai, China). LATE-BREAKING ABSTRACT: The Guangzhou COPD exacerbation study: relationship of exacerbations with viral infections and soluble biomarkers. Eur Respir J 2014; 44: Suppl. 58, 3982

Member's Comments

No comment yet.

Related content which might interest you: Etiological structure from sputum of patients with exacerbation of COPD Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections Year: 2014 Identification of nasal virus infection in patients with COPD exacerbations Source: International Congress 2014 – COPD: points to ponder Year: 2014 Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Neutrophil/lymphocyte (NLR) ratio in infectious acute exacerbations of COPD (AECOPD) Source: International Congress 2014 – Systemic biomarkers for airway diseases Year: 2014 Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 Cells biomarkers of bronchial brush-biopsies at COPD exacerbation Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system Year: 2013 Role of comorbidities on mortality in patients hospitalized for COPD exacerbations Source: International Congress 2014 – The assessment of comorbidities Year: 2014 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Blood eosinophils and exacerbations in chronic obstructive pulmonary disease: The copenhagen general population study Source: International Congress 2015 – New observations in respiratory epidemiology Year: 2015 Tree years survival rates of COPD patients that hospitalized for acute excecerbation of COPD Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD) Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013 Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Assessment of malondialdehyde in the airways during treatment of COPD exacerbations Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 LATE-BREAKING ABSTRACT: Biomarkres in exacerbations of chronic obstructive pulmonary disease (ECOPD) Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 Microbiological indicators from sputum of patients with exacerbation of COPD Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Monitoring catalase activity in COPD exacerbations Source: International Congress 2016 – Airway biomarkers Year: 2016 Biomarkers in COPD exacerbation, the role of adiponectin Source: International Congress 2014 – Predictors Year: 2014 Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014